HW: A report published in the April 21 issue of Cell shows that the small molecule rigosertib prevents Ras-dependent activation of Raf and thereby blocks cell proliferation. Which of the following oncogenes would have their proliferative signals blocked by rigosertib treatment indicating that cancers arising from any one of these oncogenes could potentially be treated with this molecule?,”HER2, Neu, ErbB

Average Rating
0 out of 5 stars. 0 votes.

HW: A report published in the April 21 issue of Cell shows that the small molecule rigosertib prevents Ras-dependent activation of Raf and thereby blocks cell proliferation. Which of the following oncogenes would have their proliferative signals blocked by rigosertib treatment indicating that cancers arising from any one of these oncogenes could potentially be treated with this molecule?,”HER2, Neu, ErbB

Ras^D”

Leave a Reply

Your email address will not be published. Required fields are marked *